Market Overview:
Spirometry is a test conducted by medical professionals to evaluate the status of lungs in order to diagnose the disorders related to the functioning of lungs. Spirometers are the medical devices that are utilized to conduct spirometry. Market Research Future (MRFR) has published a report asserting that the global spirometry market is anticipated to expand at a noteworthy CAGR of 10.03% during the forecast period of 2018-2023 and reach the valuation of USD 1,106.76 Mn by the end of 2023.
Request Free Sample copy@ https://www.marketresearchfuture.com/sample_request/6539
Market Drivers and Restraints:
Rise in prevalence of lung disorders due to increasing pollution, changing lifestyle, tobacco smoking addiction and others are inducing high demand for improved spirometry tests in the global market, which in turn is propelling the growth of the global spirometry market. Introduction of advanced medical devices that are compact and easy-to-use and increased healthcare expenditure are some other important factors that are fueling the growth of the global spirometry market. However, lack of awareness and low penetration of technologically advanced healthcare solutions are some of the major factors that are likely to restrain the growth of the global spirometry market during the assessment period.
Market Segmentation:
The global spirometry market has been segmented on the basis of product, technology, application, and end-user. Based on product, the spirometry market has been segmented into table-top spirometry, hand-held spirometry, and desktop (PC) spirometry. Based on technology, the spirometry market has been segmented into volume measurement spirometry, peak flow meters (PFM), and flow measurement spirometry. The flow measurement spirometry technology segment is sub-segmented into pneumotachograph system and mass flow meter. Based on application, the spirometry market has been segmented into diagnostic and treatment monitoring. The diagnostic segment has been sub-segmented into COPD, asthma, and interstitial pulmonary fibrosis. Based on end-users, the spirometry market has been segmented into research & academic institutes, diagnostic centers, hospitals & clinics, and home care.
Regional Analysis:
Geographically, the global human growth hormone market has been segmented into the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas accounted for the major share of 39.74% in the global spirometry market owing to the easy adoption of technically advanced medical devices, high prevalence of pulmonary disorders due to pollution and changing lifestyle and high healthcare expenditure by the population in this region. The Europe region is forecasted to expand at a significant growth rate in the global spirometry market during the assessment period owing to the high demand for advanced spirometers in the well-developed healthcare sector and proliferation of asthma cases in this region. The spirometry market in the Asia Pacific region is anticipated to expand at a notable growth rate in the global market owing to the increasing awareness regarding lung disorders and their adverse effects on health, increasing adoption of advanced healthcare solutions and high prevalence of lung disorders in this region. Improvement in healthcare infrastructure and enhanced healthcare budget are driving the spirometry market in the Middle East and Africa region.
Industry Updates:
In June 2018, Henry Schein Medical, a U.S.-based medical business of Henry Schein, Inc., has announced the launch of its new all-in-one solution for lung function testing, Henry Schein EasyOne Air spirometer. this spirometer can potentially improve recognition and diagnosis of Chronic Obstructive Pulmonary Disease (COPD).
In April 2018, NuvoAir, a Sweden-based respiratory monitor maker which was formerly known as Pond Healthcare Innovation, has launched the newest version of its home-use spirometer, a device that is portable and can be connected to smartphones and tablets via Bluetooth. This device is named as the air next, an upgrade to the previously launched device, the Air
Smart Spirometer.
Key Players:
The leading players profiled by MRFR that are operating in the global spirometry market are Carefusion Corporation (the U.S.), NDD Medical Technologies, Inc. (the U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (the U.S.), Vitalograph (the U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (the U.S.), Midmark Corporation (the U.S.), Smiths Medical Inc. (the U.S.), and Koninklijke Philips N.V. (The Netherlands).
Read More @https://www.marketresearchfuture.com/reports/spirometry-market-6539
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
No comments:
Post a Comment